SALMONELLA

VolverGo back

Resultados 54 results. LastUpdate Updated on 29/09/2022 [15:22:00] pdf PDF xls XLS

Solicitudes publicadas en los últimos 90 días / Applications published in the last 90 days



previousPage Page2/3 nextPage   results/page


Salmonella-based DNA vaccines in combination with an antibiotic

Publication No.: AU2021208400A1 11/08/2022

Applicant:

VAXIMM AG

CN_114980871_A

Absstract of: AU2021208400A1

The present invention relates to a

traducir

New Core/Shell Materials of Nanowire/Graphene on Low-Cost RFID Tags for Rapidly Sensing Live Cell Metabolites at Single-Cell Sensitivity

Publication No.: US2022252597A1 11/08/2022

Applicant:

UNIV ARKANSAS [US]

Absstract of: US2022252597A1

A biosensor having a core/shell nanocomposite of TiO2/rGO formed by hydrothermally coating reduced graphene oxide (rGO) flakes on titanate nanowires.

traducir

A NOVEL METHOD FOR DETERCTION OF SALMONELLA TYPHI

Publication No.: MY192219A 09/08/2022

Applicant:

INSTITUTE FOR MEDICAL RES MINISTRY OF HEALTH MALAYSIA [MY]

Absstract of: MY192219A

The present invention relates to a sequence-specific DNA probe for use in detecting an amplified selected target gene from the genomic DNA of Salmonella Typhi present in environmental samples or clinical samples or cultures isolated therefrom. The present invention also relates to a method and a kit for detecting the presence of Salmonella Typhi involving the use of said probe.

traducir

一种肠炎沙门氏菌活疫苗

Publication No.: CN114854654A 05/08/2022

Applicant:

青岛易邦生物工程有限公司

Absstract of: CN114854654A

本发明提供一种禽肠炎沙门氏菌活疫苗,包含有抗原和佐剂,其中抗原是活的肠炎沙门氏菌(Salmonella enterica)R073△aroA株,其保藏编号为CCTCC M 2022376。所述的肠炎沙门氏菌R073ΔaroA株是通过Red/ET同源重组系统把肠炎沙门氏菌R073株的aroA基因缺失制备的。本发明所提供的肠炎沙门氏菌疫苗可以通过传统的方法进行使用,比如通过经济易操作的喷雾和饮用水进行大规模的施用,也可以通过肌肉注射或其他的方式进行施用。

traducir

特异性识别鼠伤寒沙门氏菌的T细胞亚群及其应用

Publication No.: CN114854686A 05/08/2022

Applicant:

中国农业大学

Absstract of: CN114854686A

本发明公开了特异性识别鼠伤寒沙门氏菌的T细胞亚群及其应用。具体地公开了特异性识别鼠伤寒沙门氏菌的CD4+TCRVβ6+T细胞亚群在制备用于治疗沙门氏菌病、筛选治疗沙门氏菌病的候选药物、制备用于增强机体抵抗和清除沙门氏菌感染的药物以及在抗鼠伤寒沙门氏菌的疫苗研究中的应用。本发明还提供了一种构建沙门氏菌病TCRβ链基因测序文库的方法。本发明首次发现了CD4+TCRVβ6+T细胞亚群具有特异性识别鼠伤寒沙门氏菌的功能,用鼠伤寒沙门氏菌感染小鼠后,CD4+TCRVβ6+T细胞亚群的频率显著升高,经实验表明CD4+TCRVβ6+T细胞亚群在抵抗和清除沙门氏菌感染的过程中具有重要作用。

traducir

Vaccine composition containing novel type of inactivated Salmonella Enteritidis whole cells for preventing or treating salmonellosis

Publication No.: KR20220109129A 04/08/2022

Applicant:

INDUSTRIAL COOPERATION FOUNDATION JEONBUK NATIONAL UNIV [KR]

Absstract of: KR20220109129A

본 발명은 살모넬라 엔터라이티디스 불활화 사균체를 포함하는 산업동물에서 살모넬라 엔터라이티디스에 의한 살모넬라증의 예방 또는 치료용 백신 조성물에 관한 것이다.

traducir

INACTIVATING PATHOGENS AND PRODUCING HIGHLY IMMUNOGENIC INACTIVATED VACCINES USING A DUAL OXIDATION PROCESS

Publication No.: US2022241395A1 04/08/2022

Applicant:

NAJIT TECH INC [US]

US_2021196812_A1

Absstract of: US2022241395A1

Provided are surprisingly effective methods for inactivating pathogens, and for producing highly immunogenic vaccine compositions containing an inactivated pathogen rendered noninfectious by exposure to a Fenton reagent, or by exposure to a Fenton reagent or a component thereof in combination with a methisazone reagent selected from the group consisting of methisazone, methisazone analogs, functional group(s)/substructure(s) of methisazone, and combinations thereof. The methods efficiently inactivate pathogens, while substantially retaining pathogen antigenicity and/or immunogenicity, and are suitable for inactivating pathogens, or for the preparation of vaccines for a wide variety of pathogens with genomes comprising RNA or DNA, including viruses and bacteria. Also provided are highly immunogenic inactivated vaccine compositions prepared by using any of the disclosed methods, and methods for eliciting an immune response in a subject by administering such vaccine compositions.

traducir

DETECTING BETA-LACTAMASE ENZYME ACTIVITY

Publication No.: WO2022162303A1 04/08/2022

Applicant:

COMMISSARIAT ENERGIE ATOMIQUE [FR]
UNIV PARIS SACLAY [FR]

Absstract of: WO2022162303A1

It is essential to have efficient, simple, quick and transportable tools for reliably identifying bacteria that are multiresistant to antibiotics, more specifically broad-spectrum beta-lactamase (BSBL)-producing Enterobacteriaceae, which are the most widespread among Enterobacteriaceae. The present invention meets this requirement through its ease of use and its speed. The invention is based on detecting the enzyme activity of beta-lactam hydrolysis using an antibody capable of discriminating between the intact form of the beta-lactam ring of a beta-lactam and its hydrolysis product. This antibody can be used in kits and methods enabling for rapidly detecting (in less than one hour), without using expensive equipment (a small strip visible to the naked eye), the presence of bacteria producing penicillin-type, plasmid-mediated or hyper-produced AmpC enzymes, of BSBL or carbapenemase from colonies or in a sample.

traducir

Immunogenic compositions against enteric diseases and methods for its preparation thereof

Publication No.: GB2603362A 03/08/2022

Applicant:

SERUM INSTITUTE OF INDIA PVT LTD [IN]

CN_114728053_A

Absstract of: GB2603362A

The present disclosure relates to novel immunogenic monovalent and multivalent polysaccharide-protein conjugate vaccine compositions comprising a polysaccharide selected from Salmonella serovar strains S. typhi; S. paratyphi A; S. typhimurium and S. enteritidis and alternative improved methods of polysaccharide fermentation, polysaccharide purification, polysaccharide-protein conjugation and stable formulation. The present disclosure further relates to methods for inducing an immune response in subjects against Salmonella typhi and non-typhi related diseases and/or for reducing or preventing Salmonella typhi and non-typhi related diseases in subjects using the compositions disclosed herein. The vaccine elicits bactericidal antibodies and is useful for prevention of gastroenteritis, enteric and typhoid fever.

traducir

GM-CSF Gene Construct for Secreting GM-CSF and Anticancer Recombinant Microbials Transformed thereby

Publication No.: KR20220107741A 02/08/2022

Applicant:

IAC IN NAT UNIV CHUNGNAM [KR]
UNIV NAT CHONNAM IND FOUND [KR]

Absstract of: KR20220107741A

본 발명은 면역 유도능을 갖는 GM-CSF를 체내에서 분비할 수 있도록 하는 유전자 구조물과, 이에 의해 형질전환되어 체내에서 GM-CSF를 안정적으로 분비하는 것에 의해 항암 활성을 갖는 항암 균주에 관한 것으로, 보다 상세하게는 항 시그마 팩터 flgM 유전자와 GM-CSF 단백질을 암호화하는 유전자가 연결되어 flgM과 GM-CSF의 융합단백질을 암호화하는 것을 특징으로 하는 유전자 구조물과 이에 의해 형질전환되어 체내에서 GM-CSF를 안정적으로 분비하는 것에 의해 항암 활성을 갖는 항암 균주에 관한 것이다.

traducir

Appratuses for seperation using the magnetically driven internal reflux of magnetic particles inside a fluidic channel and methodes using thereof

Publication No.: KR20220106271A 29/07/2022

Applicant:

POSTECH RES & BUSINESS DEV FOUND [KR]

Absstract of: KR20220106271A

본 발명은 자성입자를 이용한 분리 장치 및 이를 이용하는 분리 방법에 관한 것으로서, 보다 상세하게는 자성입자의 순환을 이용한 분리장치 및 분리 방법에 관한 것이다. 본 발명에 따른 분리 장치는 자성입자에 고정되는 피분리 물질을 포함하는 유체가 흐르는 유체 채널; 상기 유체 채널의 상류에서 자성입자들을 고정시키는 제1 자석; 상기 유체 채널의 하류에서 자성입자들을 유체 항력이 제1 자석의 자력보다 작은 영역으로 이동시키는 제2 자석; 및 자성입자들을 포함한다.

traducir

MICROCIN MCCY, AND PREPARATION METHOD AND USE THEREOF

Publication No.: US2022235098A1 28/07/2022

Applicant:

UNIV SOUTH CHINA AGRICULT [CN]

WO_2022156055_A1

Absstract of: US2022235098A1

The present disclosure discloses a Microcin MccY, and a preparation method and use thereof, wherein the amino acid sequence of the Microcin MccY is GGRGHIAEYFSGPITQVSFYG. Compared with Microcin MccJ25 that only has a bactericidal activity against a small part of serotypes of Salmonella such as Salmonella enteritidis, the Microcin MccY has bacteriostatic/bactericidal effects on Salmonella Pullorum, Salmonella typhimurium, Salmonella kentucky, Salmonella Infantis, Salmonella London, and Shigella sonnei, and can kill other serotypes of Salmonella that MccJ25 cannot kill. Especially, the Microcin MccY has an outstanding bactericidal effect on Salmonella typhimurium and Salmonella Pullorum which are common in livestock and poultry production, and meanwhile it also has bacteriostatic/bactericidal effects on Shigella sonnei. Therefore, the Microcin MccY overcomes the shortcoming of the narrow spectrum of the Microcin, has breakthrough significance, and has the potential as a substitute to antibiotics.

traducir

METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STxB) MONOMERS AND OLIGOMERS, AND USES THEREOF

Publication No.: US2022233673A1 28/07/2022

Applicant:

INST CURIE [FR]
CENTRE NAT RECH SCIENT [FR]
INST NAT SANTE RECH MED [FR]
COMMISSARIAT A LENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES CEA [FR]
APHP ASSIST PUBLIQUE HOPITAUX DE PARIS [FR]
UNIV PARIS [FR]
UNIV OF UTAH RESEARCH FOUDATION [US]
UNIV UTAH RES FOUND [US]

WO_2020245321_A1

Absstract of: US2022233673A1

A method of producing a monomer of a Shiga toxin B-subunit (STxB) protein or of a variant thereof by peptide chemical synthesis, as well as to a method of producing a pentamer of the STxB protein or of the variant thereof. The methods are particularly advantageous as they overcome major issues typically observed in peptide chemical synthesis, including solubility and purity issues.

traducir

MICROCIN MCCY, AND PREPARATION METHOD THEREFOR AND USE THEREOF

Publication No.: WO2022156055A1 28/07/2022

Applicant:

UNIV SOUTH CHINA AGRICULT [CN]

US_2022235098_A1

Absstract of: WO2022156055A1

Provided is the microcin MccY, wherein the amino acid sequence of the microcin is GGRGHIAEYFSGPITQVAFYG. Further provided are a method for preparing the microcin and the use thereof. Compared with MccJ25 which only has bactericidal activity on a small part of serotype salmonella such as enteritis, the small rhizomorph MccY has a bacteriostatic/bactericidal effect on Salmonella pullorum, Salmonella typhimurium, Salmonella kentucky, Salmonella infantis, Salmonella London and Shigella sonnei, and can kill other salmonella serotypes which cannot be killed by MccJ25; in particular, the small rhizomorph MccY has a remarkable bactericidal effect on Salmonella typhimurium and Salmonella pullorum which are common in livestock and poultry production, also has a bacteriostatic/bactericidal effect on Shigella sonnei, thereby overcoming the shortcoming of the small rhizomorph having a narrow spectrum.

traducir

Bacteria-based protein delivery

Publication No.: JP2022109967A 28/07/2022

Applicant:

ウニヴェルズィテートバーゼル

US_2021155942_A1

Absstract of: AU2015261905A1

The present invention relates to recombinant Gram-negative bacterial strains and the use thereof for delivery of heterologous proteins into eukaryotic cells.

traducir

LIVE ATTENUATED ORAL VACCINE AGAINST COVID-19 AND TYPHOID FEVER

Publication No.: US2022233681A1 28/07/2022

Applicant:

PROTEIN POTENTIAL LLC [US]

Absstract of: US2022233681A1

Disclosed herein are transgenic Salmonella typhi Ty21a comprising a chromosome with one or more heterologous nucleic acid regions, wherein the heterologous nucleic acid regions encode one or more viral antigens and are integrated into the Salmonella typhi Ty21a chromosome, and wherein the transgenic Salmonella typhi Ty21a stably expresses the one or more viral antigens. Also disclosed herein are compositions and vaccines comprising the transgenic Salmonella typhi Ty21a. Also disclosed herein are methods of eliciting an immune response in a subject against a SARS-CoV-2 viral antigen and/or a Salmonella typhi antigen comprising administering one or more doses of the composition or the vaccine to the subject. Also disclosed herein are methods of treating, preventing or reducing the incidence of COVID-19 and/or typhoid fever in a subject comprising administering one or more doses of the composition or the vaccine to the subject.

traducir

Delivery of Bacteria-Derived Outer Membrane Vesicles

Publication No.: JP2022533976A 27/07/2022

Applicant:

クアドラムインスティテュートバイオサイエンス

US_2022175901_A1

Absstract of: WO2020229846A2

Pharmaceutical compositions and preparation including outer membrane vesicles (OMVs) and at least one pharmaceutically acceptable carrier wherein said OMVs are native OMVs produced by the Gram-negative commensal bacteria Bacteroides.

traducir

BACTERIOCINS FOR CONTROL OF SALMONELLA ENTERICA

Publication No.: EP4031559A2 27/07/2022

Applicant:

NOMAD BIOSCIENCE GMBH [DE]

CN_114423780_PA

Absstract of: EP3378485A1

The present invention relates to bacteriocins for control of Salmonella enterica (salmocins). The bacteriocins are derived from Salmonella. The salmocins can be expressed in plants and can be used in a method of preventing or reducing infection or contamination of an object with Salmonella.

traducir

NOVEL VACCINE COMPOSITIONS

Publication No.: CN114786714A 22/07/2022

Applicant:

葛兰素史密丝克莱恩生物有限公司

WO_2021074352_A1

Absstract of: EP3808372A1

A Shigella flexneri O-antigen of a first serotype or subserotype for use in raising an immune response against one or more Shigella flexneri O-antigen of a different serotype or subserotype, together with associated binding moieties, pharmaceutical compositions, kits, uses or methods.

traducir

ANTIBACTERIAL AGENTS & METHODS

Publication No.: US2022226396A1 21/07/2022

Applicant:

FOLIUM FOOD SCIENCE LIMTED [GB]

JP_2022533080_A

Absstract of: US2022226396A1

The invention relates to means for carrying out conjugation between bacteria, and in particular the invention relates to carrier bacteria comprising antimicrobial agents and methods of use. The carrier bacteria are capable of conjugative transfer of DNA encoding the agent to a target cells. The invention further relates to growth or feed conversion ratio promotion in animals. The invention further relates to killing Salmonella or inhibiting the growth or proliferation of Salmonella.

traducir

ERADICATION OF BACTERIAL BIOFILM USING ANTI-AMYLOID MONOCLONAL ANTIBODIES

Publication No.: US2022227846A1 21/07/2022

Applicant:

UNIV TEMPLE [US]
LANKENAU INSTITUTE OF MEDICAL RES [US]

JP_2021525798_A

Absstract of: US2022227846A1

The present invention features compositions comprising an anti-amyloid antibody and methods of treating microbial infection and treating or preventing microbial biofilms using the composition.

traducir

NEW IMMUNOGENIC COMPOSITIONS

Publication No.: US2022218810A1 14/07/2022

Applicant:

ETH ZUERICH [CH]

BR_112021023865_A2

Absstract of: US2022218810A1

The present invention relates to an immunogenic composition for Proteobacteria protection and reduced transmission. We have identified Proteobacteria serovar variant combinations that generate an immune response capable of robustly driving bacterial enteropathogens into an evolutionary dead end and reducing the transmission of the bacterium. These inactivated immunogenic positions and typically oral vaccines are easy to apply, cheap to produce, and can be stored long-term without cold-chain requirements making them ideal for application in livestock, or in resource-poor areas. They are believed to be the only immunogenic compositions and vaccine formulations capable of breaking the chain of transmission for these types of pathogen.

traducir

一种CpG佐剂与抗原定点共价结合方法

Publication No.: CN114732898A 12/07/2022

Applicant:

中国人民解放军军事科学院军事医学研究院

Absstract of: CN114732898A

本发明涉疫苗领域,具体而言涉及一种CpG佐剂与抗原的定点共价结合方法。本发明方法基于分步偶联策略,通过在SpyTag序列的N端或C端添加单个半胱氨酸,使其能够与马来酰亚胺修饰的CpG佐剂偶联,并利用液相色谱技术纯化制备CpG‑SpyTag;将抗原N端或C端与SpyCatcher融合表达并纯化;将融合表达的抗原与CpG‑SpyTag体外连接,获得抗原与CpG佐剂1:1摩尔比的偶联产物。根据本发明技术方面制备的偶联产物提高了疫苗免疫效果,降低了佐剂使用量。

traducir

IMMUNOGENIC COMPOSITIONS AGAINST ENTERIC DISEASES AND METHODS FOR ITS PREPARATION THEREOF

Publication No.: CN114728053A 08/07/2022

Applicant:

印度血清研究所私人有限公司

KR_20220087437_A

Absstract of: WO2021044436A2

The present disclosure relates to novel immunogenic monovalent and multivalent polysaccharide-protein conjugate vaccine compositions comprising a polysaccharide selected from Salmonella serovar strains S. typhi; S. paratyphi A; S. typhimurium and S. enteritidis and alternative improved methods of polysaccharide fermentation, polysaccharide purification, polysaccharide-protein conjugation and stable formulation. The present disclosure further relates to methods for inducing an immune response in subjects against Salmonella typhi and non-typhi related diseases and/or for reducing or preventing Salmonella typhi and non-typhi related diseases in subjects using the compositions disclosed herein. The vaccine elicits bactericidal antibodies and is useful for prevention of gastroenteritis, enteric and typhoid fever.

traducir

DOSAGE AND ADMINISTRATION OF A BACTERIAL SACCHARIDE GLYCOCONJUGATE VACCINE

Nº publicación: CN114728051A 08/07/2022

Applicant:

葛兰素史克生物有限公司

WO_2021099982_A1

Absstract of: WO2021099982A1

The present invention provides a glycoconjugate for administration to a subject in a method comprising the steps of: (i) administering a first dose of glycoconjugate; (ii) subsequently administering a second dose of glycoconjugate; wherein the amount of glycoconjugate in the first dose or first and second doses are atypically low, and also related aspects.

traducir

previousPage Page2/3 nextPage results/page

punteroimgGo back